9. In Schedule 2B—
(a)in paragraph 2—
(i)omit sub-paragraph (b);
(ii)after sub-paragraph (d)(ii), insert—
“(iia)a North American Certificate;
(iib)a certificate of COVID-19 records issued by an approved third country or territory;”;
(iii)in sub-paragraph (d)(iii) omit “or”;
(iv)in sub-paragraph (d)(iv) for “,” substitute “, and”;
(v)omit sub-paragraph (e);
(b)in paragraph 4—
(i)at the end of sub-paragraph (b), insert “and”;
(ii)in sub-paragraph (c) omit “, and”;
(iii)omit sub-paragraph (d);
(c)in paragraph 5—
(i)in sub-paragraph (a) omit “, and”;
(ii)omit sub-paragraph (b);
(d)in paragraph 6—
(i)in the opening words, omit “either”;
(ii)at the end of sub-paragraph (a), omit “, or”;
(iii)omit sub-paragraph (b);
(e)in paragraph 7, after sub-paragraph (a), insert—
“(aa)if P has received at least 2 doses of any of the vaccines referred to in sub-paragraph (c) of the definition of “authorised vaccine” in paragraph 10, P is deemed to have completed a course of doses of an authorised vaccine.”;
(f)in paragraph 7B, after sub-paragraph (2)(b), insert—
“(ba)a North American Certificate;
(bb)a certificate of COVID-19 records issued by an approved third country or territory;”;
(g)in paragraph 10—
(i)in the definition of “authorised vaccine”, in sub-paragraph (c), for the words from “would be authorised” to the end, substitute—
“—
(i)would be authorised as provided for in sub-paragraph (a)(i) or (ii) if the doses were received in the United Kingdom, or
(ii)are listed in lines 10, 11 or 13 of the guidance document “Status of COVID-19 Vaccines within WHO EUL/PQ Evaluation Process” published by the World Health Organisation on 11th November 2021(1), and authorised or certified in a regulated country listed in paragraph 12,”;
(ii)in the definition of “NHS COVID pass”—
(aa)after “records” insert “available”;
(bb)after “NHS.uk or” insert “in”;
(iii)after the definition of “NHS Wales” insert—
“”North American Certificate” means, in relation to a State, District or Province listed in the table in paragraph 10B, the certificate identified in the corresponding row of the second column of that table;”;
(h)after paragraph 10, insert—
“10A. The following countries and territories are approved third countries or territories for the purposes of this Schedule—
Albania
Armenia
Faroe Islands
Israel
Morocco
North Macedonia
Panama
Turkey
Ukraine.
10B. The table referred to in the definition of “North American Certificate” in paragraph 10 is—
State, District or Provence | Certificate Name |
---|---|
New York | Excelsior Pass Plus |
California | Digital COVID-19 Vaccine Record |
Washington State | WA Verify” |
(i)In paragraph 11, in the opening words, after “paragraph 10” insert “except in the definition of “North American Certificate””;
(j)In paragraph 12, in the list of countries and territories, at the appropriate places insert entries for—
“Belarus
Bolivia
British Antarctic Territory
British Indian Ocean Territory
British Virgin Islands
Democratic Republic of Congo
Dominican Republic
Ecuador
Falkland Islands
Guernsey
Isle of Man
Jersey
Laos
Libya
Malawi
Montserrat
Mozambique
Pitcairn, Henderson, Ducie and Oeno Islands
Samoa
Senegal
South Georgia and the South Sandwich Islands
the Soverign Base Areas of Akrotiri and Dhekelia in the Island of Cyprus
St Helena, Ascension and Tristan da Cunha
Turks and Caicos Islands
Vanuatu
Zambia
Zimbabwe”.
Commencement Information
I1Reg. 9 in operation at 22.11.2021 at 4.00 a.m., see reg. 1(2)
A copy may be downloaded from https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_11Nov2021.pdf. A hard copy may be obtained from the Department of Health and Social Care, 39 Victoria Street, London, SW1H 0EU